![Profile photo: Michał Beffinger](/assets/michal-beffinger,59581-1/photo.png)
Michał Beffinger
Employment
Publications
Filters
total: 2
Catalog Publications
Year 2015
-
Targeting of FLT3-ITD kinase contributes to high selectivity of imidazoacridinone C-1311 against FLT3-activated leukemia cells
PublicationDrugs targeting receptor tyrosine kinase FLT3 are of particular interest since activating FLT3-internal tandem duplication (ITD) mutations abundantly occur in fatal acute myeloid leukemias (AMLs). Imidazoacridinone C-1311, a DNA-reactive inhibitor of topoisomerase II, has been previously shown to be a potent and selective inhibitor of recombinant FLT3. Here, we expand those findings by studying its effect on leukemia cells with...
Year 2012
-
The Role of FLT3 Kinase as an AML Therapy Target
Publication...
seen 312 times